Stig Anders Lindberg

Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.

Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.

Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden.

Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.

Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden.

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden.

Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.

Part of Oncopeptides AB, Oncopeptides, Inc. is a private company committed to developing therapies for difficult-to-treat hematological diseases. The company is based in Waltham, MA. Oncopeptides strives to bring hope to patients through science and innovation, and is dedicated to bringing forward new and meaningful treatment options. The company is inspired by the perseverance of patients, caregivers, and healthcare providers in their fight against cancer. Oncopeptides' focus is on the development of therapies that can make a difference in the lives of those affected by hematological diseases.

Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden.

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden.

Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden.

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden.

Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden.